Atrial Fibrillation Surgery Market Players:
- Abbott Laboratories.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AtriCure, Inc.,
- Biosense Webster, Inc.,
- Boehringer Ingelheim GmbH
- Boston Scientific Corporation
- Bristol-Myers Squibb Corporation
- CardioFocus, Inc.,
- Endoscopic Technologies, Inc.,
- Sanofi Aventis,
- Johnson and Johnson Ltd.,
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of atrial fibrillation surgery is evaluated at USD 5.21 billion.
The global atrial fibrillation surgery market size exceeded USD 4.65 billion in 2025 and is set to expand at a CAGR of over 13.4%, surpassing USD 16.35 billion revenue by 2035.
The North America atrial fibrillation surgery market is expected to hold a 32% share by 2035, driven by technological advancements, increasing prevalence of cardiac conditions, and favorable insurance coverage.
Key players in the market include Abbott Laboratories., AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Johnson and Johnson Ltd.
